NYXH (NYXH) Stock Price & Analysis
NYXH (NYXH) fell 3.70% to USD 1.56 as of September 9, 2026 at 12:45 UTC, according to Nexqual real-time market data.
NYXH last closed at USD 1.56; the session ranged USD 1.54–1.64 on volume of 373,163 shares. Market capitalization is —, with a 52-week range of USD 1.26–6.88 (NGM). Source: Nexqual, September 9, 2026 at 12:45 UTC.
Key Statistics (as of September 9, 2026 at 12:45 UTC)
| Price | USD 1.56 |
|---|---|
| Change | ▼ 3.70% (down) |
| Previous Close | USD 1.56 |
| Open | USD 1.56 |
| Day Range | USD 1.54 – 1.64 |
| 52-Week Range | USD 1.26 – 6.88 |
| Volume | 373,163 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (NYXH)
Nexqual's technical model rates NYXH "SELL" based on 1 bullish and 4 bearish signals across 127 daily candles, as of September 9, 2026 at 12:45 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 48.48 (neutral) |
| vs SMA50 | Below (USD 1.57) |
| MACD | 0.01 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NPCE | Neuropace, Inc. | USD 14.76 | ▲ 0.07% |
| CVRX | CVRx, Inc. | USD 2.93 | ▼ 2.66% |
| MOLN | Molecular Partners AG | USD 4.35 | ▲ 0% |
| SGHT | Sight Sciences, Inc. | USD 8.1 | ▼ 3.34% |
| SERA | Sera Prognostics, Inc. | USD 2.01 | ▲ 1.52% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 12:45 UTC. This page is informational and not investment advice.